This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Angus V. P. Mackay, MB, PhD; Leslie L. Iversen, MA, PhD; Martin Rossor, MB; Ernest Spokes, MD; Edward Bird, MD; Alberto Arregui, MD; Ian Creese, PhD; Solomon H. Snyder, MD

Arch Gen Psychiatry. 1982;39(9):991-997.

Abstract
• In postmortem samples of caudate nucleus and nucleus accumbens from 48 schizophrenic patients, there were significant increases in both the maximum number of binding sites (B_max) and the apparent dissociation constant (K_D) for tritiated spiperone. The increase in apparent K_D probably reflects the presence of residual neuroleptic drugs, but changes in B_max for tritiated spiperone reflect genuine changes in receptor numbers. The increases in receptors were seen only in patients in whom neuroleptic medication had been maintained until the time of death, indicating that they may be entirely iatrogenic. Dopamine measurements for a larger series of schizophrenic and control cases (n > 60) show significantly increased concentrations in both the nucleus accumbens and caudate nucleus. The changes in dopamine were not obviously related to neuroleptic medication and, unlike the receptor changes, were most severe in younger patients.

Author Affiliations
From the MRC Neurochemical Pharmacology Unit, Medical Research Council Centre, Medical School, Cambridge, England (Drs Mackay, Iversen, Rossor, Spokes, and Bird), and the Departments of Neuroscience, Neurology, and Psychiatry and Pharmacology, The Johns Hopkins University School of Medicine, Baltimore (Drs Arregui, Creese, and Snyder). Dr Mackay is now with the Argyll and Bute Hospital, Lochgilphead, Argyll, United Kingdom.

Footnotes
Accepted for publication Dec 31, 1981.

Reprint requests to Argyll and Bute Hospital, Lochgilphead, PA31 8LD Argyll, United Kingdom (Dr Mackay).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dopamine Genes and Schizophrenia: Case Closed or Evidence Pending?
Talkowski et al.
Schizophr Bull 2007;33:1071-1081.
ABSTRACT | FULL TEXT  

Morphometry of the Superior Temporal Plane In Schizophrenia: Relationship to Clinical Correlates
Crespo-Facorro et al.
J. Neuropsychiatry Clin. Neurosi. 2004;16:284-294.
ABSTRACT | FULL TEXT  

Dopamine and antipsychotic drug action revisited
JONES and PILOWSKY
Br. J. Psychiatry 2002;181:271-275.
FULL TEXT  

Striatal Size and Relative Glucose Metabolic Rate in Schizotypal Personality Disorder and Schizophrenia
Shihabuddin et al.
Arch Gen Psychiatry 2001;58:877-884.
ABSTRACT | FULL TEXT  

Convergence and Plasticity of Monoaminergic Systems in the Medial Prefrontal Cortex during the Postnatal Period: Implications for the Development of Psychopathology
Benes et al.
Cereb Cortex 2000;10:1014-1027.
ABSTRACT | FULL TEXT  

Dopamine Receptor Transcript Expression in Striatum and Prefrontal and Occipital Cortex: Focal Abnormalities in Orbitofrontal Cortex in Schizophrenia
Meador-Woodruff et al.
Arch Gen Psychiatry 1997;54:1089-1095.
ABSTRACT  

Mesolimbic Dopamine D3 Receptors and Use of Antipsychotics in Patients With Schizophrenia: A Postmortem Study
Gurevich et al.
Arch Gen Psychiatry 1997;54:225-232.
ABSTRACT  

Striatal D2 Dopamine Receptor Characteristics in Neuroleptic-Naive Schizophrenic Patients Studied With Positron Emission Tomography
Hietala et al.
Arch Gen Psychiatry 1994;51:116-123.
ABSTRACT  

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects
Farde et al.
Arch Gen Psychiatry 1992;49:538-544.
ABSTRACT  

Abnormal Reinnervation as a Basis for Schizophrenia: A Hypothesis
Stevens
Arch Gen Psychiatry 1992;49:238-243.
ABSTRACT  

Merck, Sharp & Dohme Prize for Young Psychopharmacologists: A history of frontal and temporal lobe aspects of the neuropharmacology of schizophrenia
Kerwin
J Psychopharmacol 1992;6:230-240.
ABSTRACT  

D2 Dopamine Receptors in Neuroleptic-Naive Schizophrenic Patients: A Positron Emission Tomography Study With [11C]Raclopride
Farde et al.
Arch Gen Psychiatry 1990;47:213-219.
ABSTRACT  

Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde et al.
Arch Gen Psychiatry 1988;45:71-76.
ABSTRACT  

No D2 Receptor Increase in PET Study of Schizophrenia
Farde et al.
Arch Gen Psychiatry 1987;44:671-672.
ABSTRACT  

Is it possible to model psychotic states in animals?
Iversen
J Psychopharmacol 1987;1:154-176.
 

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics
Wong et al.
Science 1986;234:1558-1563.
ABSTRACT  

Dopamine Metabolism in the Cerebrospinal Fluid of Drug-Free Schizophrenic Patients With and Without Cortical Atrophy
van Kammen et al.
Arch Gen Psychiatry 1986;43:978-983.
ABSTRACT  

Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage
Bogerts et al.
Arch Gen Psychiatry 1985;42:784-791.
ABSTRACT  

Schneider's First-Rank Symptoms of Schizophrenia: An Association With Increased Growth Hormone Response to Apomorphine
Whalley et al.
Arch Gen Psychiatry 1984;41:1040-1043.
ABSTRACT  

Bimodal distribution of dopamine receptor densities in brains of schizophrenics
Seeman et al.
Science 1984;225:728-731.
ABSTRACT  

Imaging dopamine receptors in the human brain by positron tomography
Wagner et al.
Science 1983;221:1264-1266.
ABSTRACT  

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy
van Kammen et al.
Science 1983;220:974-977.
ABSTRACT